Navigation Links
Biopure Announces 2008 First Quarter Financial Results
Date:2/21/2008

BIOPURE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

Three Months Ended

January 31

2008 2007

Total revenues $573 $594

Cost of revenues 2,788 3,162

Gross loss (2,215) (2,568)

Operating expenses:

Research and development 1,487 1,915

Sales and marketing 280 392

General and administrative 1,996 2,231

Total operating expenses 3,763 4,538

Loss from operations (5,978) (7,106)

Other income, net 176 178

Net loss $(5,802) $(6,928)

Basic and diluted net loss per

common share $(0.17) $(0.53)

Weighted-average common shares

outstanding 33,918 12,955

The net loss per common share for the three month period ended January 31,

2007 has been adjusted to reflect the one-for-five reverse split that took

effect on October 2, 2007.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

(Unaudited)

January 31, 2008 October 31, 2007

Assets

Total current assets $14,443
'/>"/>

SOURCE Biopure Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Biopure Launches Updated Website
2. Biopure Announces Pricing of Equity Offering
3. Biopure Gives Update on Malaysia Joint Venture Discussions
4. PPD Announces Plan to Repurchase Shares of its Common Stock
5. 3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results
6. 5AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal
7. Sunesis Pharmaceuticals Announces Milestone Payment from Inflammation Collaboration
8. Neuralstem Inc. Announces Strategic Investment by Korean CJ CheilJedang Corporation
9. Inverness Medical Innovations Announces Fourth Quarter 2007 Results
10. Telik Announces Revised Date for Year-End Financial Release, Conference Call and Webcast
11. 3SBio Inc. Announces Change to the Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015  Moerae Matrix Inc. ... 1 clinical trial with MMI-0100, a first-in-class inhibitor ... developed for pulmonary disorders characterized by inflammation and ... United Kingdom , is a double-blind, two-way ... the safety and tolerability of MMI-0100 when given ...
(Date:7/28/2015)... SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., July 28, ... ) today announced its financial results for the ... ®  sales grew nearly 300% as compared to ... was first launched," said Roger Jeffs, Ph.D., United ... in Orenitram sales was due to an increase ...
(Date:7/27/2015)... Tenn. , July 27, 2015  Capella ... care services and one of the largest for-profit ... its parent company and sole stockholder, Capella Holdings, ... Properties Trust, Inc. ("MPT") (NYSE: MPW ) ... The transaction is expected to be finalized during ...
(Date:7/27/2015)... ... July 27, 2015 , ... Brady (NYSE:BRC), ... video: 3 Ways to GHS Labels . This video provides useful information ... System (GHS) by effectively labeling chemical containers. , “With the fourth and final ...
Breaking Biology Technology:Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 2United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 3United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 4United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 5United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 6United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 7United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 8United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 9United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 10United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 11Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 2Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 3Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 4Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 5Brady Releases “3 Roads to GHS Labels” Video 2
... ... ... Agricultural improvements will play a key role in tackling Africa’s crucial problems of hunger ... during the World Economic Forum on Africa. , , , , ,“Local infrastructure that ...
... May 6, 2010 Oramed,Pharmaceuticals Inc. (OTCBB: ORMP), a developer ... Phase 2b non-FDA,clinical trial of its flagship oral insulin capsule, ORMD-0801. ... ... Africa evaluated responses of 29 Type 2 diabetes patients,to ORMD-0801. ...
... ... ... -- ProRepro today announced it has become an Autodesk authorized value-added reseller (VAR). ... California. ProRepro’s qualified staff demonstrates in-depth technical and industry knowledge and a commitment to ...
Cached Biology Technology:DuPont Leader: Agricultural Improvements Key to Meeting Growing Food, Water Needs in Africa 2Oramed Pharmaceuticals Reports Results in Phase 2b Trial of Oral Insulin Administration to Type 2 Diabetes Patients 2Oramed Pharmaceuticals Reports Results in Phase 2b Trial of Oral Insulin Administration to Type 2 Diabetes Patients 3ProRepro Becomes a Value-Added Reseller for Autodesk 2
(Date:7/23/2015)... Research and Markets ( http://www.researchandmarkets.com/research/rzzp3v/global_outlook_of ) ... Outlook of the Biometrics Industry 2015 " ... global biometrics market is likely to witness significant ... to the uptake of multiple technologies available. The ... the growth of biometrics in existing applications as ...
(Date:7/21/2015)... , July 21, 2015  NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile ... wallet, announces that it has filed provisional patent ... Method. This invention highlights next ... authorizes an account, but also the user using ...
(Date:7/20/2015)... , July 20, 2015  Acuity Market ... Report: The Convergence of Commerce and Privacy" forecasts ... mobile biometric apps will be downloaded to smart ... The mobile biometrics market is projected to generate ... revenue during the seven-year forecast period.    ...
Breaking Biology News(10 mins):Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2
... , April 17, 2013 /PRNewswire-iReach/ -- 2013  Infectious ... of Department of Defense (DoD) clinical and research ... challenges facing the military, revealed that it is ... conduct a completely paperless clinical study resulting in ...
... Institute for Natural Resources, (INR) Oregon Biodiversity Information ... last night at the NatureServe network,s annual Biodiversity ... recognizes ORBIC,s leadership in engaging network members in ... ORBIC is one of three members of the ...
... Heritage Program (NCNHP) received the 2013 Scientific and Technical ... Biodiversity Without Boundaries conference in Baltimore. , "This ... achievement of the North Carolina Natural Heritage Program in ... and CEO of NatureServe. "This is the second part ...
Cached Biology News:Federal Government Organization achieves cleaner and faster Clinical Study Data using Tablet PCs from TabletKiosk 2Oregon Biodiversity Information Center wins 2013 Natureserve Network Collaboration Award 2North Carolina Natural Heritage Program earns 2013 Award for Science and Technical Achievement 2
Applications: Beadlyte® assay Stability: 2 years at 4°C (lyophilized) or 6 months at -20°C (rehydrated) ...
Dnase and Rnase free...
... Quality 96 Well BAC Prep; ... preparation from 1.5ml 2xYT cultures; ... automated fluorescent sequencing for small ... ProPrep strategy which minimizes shearing ...
Olig2 Immunogen: Synthetic peptide from rat. Available Date: 9-19-2006...
Biology Products: